| 发明名称 |
COMBRETASTATINS FOR PREVENTION OF POSTERIOR CAPSULE OPACIFICATION |
| 摘要 |
597573 Disclosed herein is the use of a combretastatin, such as combretastatin A-4 (CA4P) or a phosphate prodrug thereof, in the treatment or prevention of posterior capsule opacification. In one embodiment the combretastatin is compound of formula II.
|
| 申请公布号 |
NZ597573(A) |
申请公布日期 |
2013.10.25 |
| 申请号 |
NZ20100597573 |
申请日期 |
2010.07.02 |
| 申请人 |
OXIGENE, INC. |
发明人 |
QUINLAN, ROY;THOLOZAN, FREDERIQUE |
| 分类号 |
C07F9/02 |
主分类号 |
C07F9/02 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
